ArticleOncology letters2025
Predicting pathological staging of non-small cell lung cancer using a multi-task radiomics model integrating intratumoral and peritumoral features.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pathological staging is essential for guiding treatment decisions and determining prognosis in patients with non-small cell lung cancer (NSCLC). The present study aimed to establish a model using intratumoral and peritumoral features from computed tomography radiomics data and a multi-task learning algorithm, and evaluate its predictive performance for the pathological stage of NSCLC. Data from 198 eligible patients with NSCLC from The Cancer Imaging Archive database were retrospectively analyzed, which was used to develop four radiomics models to classify the pathological stages of NSCLC. These models combined the traditional random forest and multi-task random forest algorithms with the volumes of interest for the intratumoral region alone and with the intratumoral and peritumoral regions combined. Subsequently, the data from 90 patients from a real-world dataset were collected for use as an external test set. Diagnostic performance was evaluated using accuracy, precision, sensitivity, specificity, F1 scores and receiver operating characteristic curves. The results revealed that, in the internal test set, the area under the curve (AUC) values for model 1 (single-task model based on the intratumoral region), model 2 (single-task model combining intra- and peritumoral regions), model 3 (multi-task model based on the intratumoral region) and model 4 (multi-task model combining intra- and peritumoral regions) were 0.814, 0.900, 0.896 and 0.938, respectively. In the external test set, the AUC values were 0.821, 0.921, 0.858 and 0.939, separately. Moreover, the results of the DeLong test indicated that the AUC difference between model 1 and 4 was statistically significant (P<0.05). In conclusion, the multi-task radiomic model incorporating both intratumoral and peritumoral regions demonstrated favorable diagnostic efficacy in the predictive pathological staging of NSCLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.